PDE10A and juvenile Huntington disease: In addition, the inhibition of PDE10A (the striatal-specific PDE) in a mouse model of Huntington’s disease resulted in significant amelioration in striatal cell survival, elevated levels of BDNF and phosphorylated CREB, as well as improvement in rotarod performance [16].